OPS Environmental Impact Review at CDER: ENVIRONMENTAL IMPACT: CLAIMS FOR CATEGORICAL EXCLUSION
Similar Posts
Thea Pharma, Inc. – 712416 – 07/09/2025
Unapproved New Drugs/MisbrandedAntifungal Susceptibility Test Interpretive Criteria
Antifungal Susceptibility Test Interpretive CriteriaAnimal Model Qualification Program | AMQP
Information for requestors interested in submitting animal models for qualification to FDA’s Drug Development Tool (DDT) Programs.A.S.K. Foods, LLC Issues Allergy Alert on Undeclared Soy in Publix Rice & Pigeon Peas
A.S.K. Foods, LLC of Palmyra, PA is recalling select 32 oz. containers of Publix Rice & Pigeon Peas because it contains undeclared soy. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction if they consume this product.Ultra Seal Corporation – 624650 – 09/25/2024
CGMP/Finished Pharmaceuticals/AdulteratedFDA Provides Guidance on Remote Interactive Evaluations for Oversight of Drug Facilities During COVID-19
FDA releases guidance on how remote interactive evaluations will be requested by FDA and conducted for the duration of COVID-19 at drug facilities.